
Pfizer axes new weight loss pill after patients experience serious side effects
Pfizer is discontinuing danuglipron, its twice-daily weight loss pill, after more than half of patients in a clinical trial stopped taking it.
Pfizer is discontinuing danuglipron, its twice-daily weight loss pill, after more than half of patients in a clinical trial stopped taking it.